Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research Solutions, Inc.
LOS ANGELES, May 16, 2014 /PRNewswire/ -- Research Solutions, Inc. (RSSS), a pioneer in facilitating the flow of information from the publishers of scientific, technical, and medical content to enterprise customers in Life Sciences and other research intensive organizations around the world, today announced two webinars to highlight how QUOSA from Elsevier and Article Galaxy from Research Solutions' wholly-owned subsidiary Reprints Desk can be used together to efficiently acquire, manage and share relevant scientific literature for Medical Liaisons, Medical Communications, and other groups within Medical Affairs. Online registration is free and available at: http://www.elsevier.com/online-tools/quosa/news/webinar-streamlining-medical-affairs-workflows.
The webinars will explore how corporate libraries, information centers, and Medical Affairs staff can improve the tasks they normally perform today, including:
The QUOSA solution is a centralized repository of scientific literature that enables life sciences institutions to meet regulatory reporting requirements, address medical inquiries and maintain current awareness in relation to topics or authors. It is used by a broad array of groups such as pharmacovigilance and medical affairs personnel in pharma, biotech and medical device companies. QUOSA is part of Elsevier's Life Science Solutions, a portfolio of interoperable, domain-specific, decision support tools which span the discovery and development workflow; including Pathway Studio™, Reaxys ®, Reaxys ® Medicinal Chemistry, ScienceDirect, Scopus, PharmaPendium® and Embase®.
Corporations, academic institutions, and government organizations around the world rely on Reprints Desk and its Article Galaxy online platform for single article document delivery research retrieval for obtaining copyrighted journal content that complies with applicable copyright laws when subscriptions do not exist. Since 2008 Reprints Desk has held lone honors as the top-rated document supplier in the document delivery market research survey conducted by information analyst and advisory firm Outsell, Inc.
About Research Solutions®
Research Solutions, Inc. is a pioneer in facilitating the flow of information from the publishers of scientific, technical, and medical content to enterprise customers in life science and other research intensive organizations around the world. We develop products, services and systems to facilitate the re-use of published content in a manner that helps organizations achieve their research, marketing, and communication goals effectively and in compliance with copyright law and regulatory rules. Our subsidiary companies include Reprints Desk, Inc. and Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). For more information, please visit www.researchsolutions.com.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in the Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008.
Certain matters discussed in this press release may be forward-looking statements. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. Examples of forward-looking statements in this release include statements related the Company's products. The Company assumes no obligation to update the cautionary information in this release.
©2012 PR Newswire. All Rights Reserved.